Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason T Huse

Showing results (1-10 of 188) with videos related to

Pageof 19
Sort By:
Neuro-Oncology|July 3, 2022
A promising preclinical model for TERT promoter mutation in glioblastomaJason T Huse
Neuro-Oncology|October 15, 2025
Advancing intraoperative diagnostics, one (or rather three) mutations at a timeJason T Huse
Surgical Pathology Clinics|August 16, 2016
Establishing a Robust Molecular Taxonomy for Diffuse Gliomas of AdulthoodJason T Huse
Neuro-Oncology|December 3, 2014
TERT promoter mutation designates biologically aggressive primary glioblastomaJason T Huse
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 13, 2022
The epigenetic dysfunction underlying malignant glioma pathogenesisSharvari Dharmaiah, Jason T Huse
Molecular & Cellular Oncology|September 29, 2018
Novel insights into the epigenetics of diffuse gliomaCarla Danussi, Jason T Huse
Advances in Anatomic Pathology|February 10, 2015
The evolving molecular genetics of low-grade gliomaSriram Venneti, Jason T Huse
Current Neurology and Neuroscience Reports|November 24, 2021
The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021Alejandro Perez, Jason T Huse
Acta Neuropathologica Communications|April 30, 2025
Neurotransmitter power plays: the synaptic communication nexus shaping brain cancerJayanta Mondal, Jason T Huse
Neuro-Oncology|October 19, 2014
CMV and glioma--are we there yet?Jason T Huse, Kenneth Aldape
Pageof 19

Showing results (1-10 of 188) with videos related to

Sort By:
Pageof 19
Neuro-Oncology|July 3, 2022
A promising preclinical model for TERT promoter mutation in glioblastomaJason T Huse
Neuro-Oncology|October 15, 2025
Advancing intraoperative diagnostics, one (or rather three) mutations at a timeJason T Huse
Surgical Pathology Clinics|August 16, 2016
Establishing a Robust Molecular Taxonomy for Diffuse Gliomas of AdulthoodJason T Huse
Neuro-Oncology|December 3, 2014
TERT promoter mutation designates biologically aggressive primary glioblastomaJason T Huse
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 13, 2022
The epigenetic dysfunction underlying malignant glioma pathogenesisSharvari Dharmaiah, Jason T Huse
Molecular & Cellular Oncology|September 29, 2018
Novel insights into the epigenetics of diffuse gliomaCarla Danussi, Jason T Huse
Advances in Anatomic Pathology|February 10, 2015
The evolving molecular genetics of low-grade gliomaSriram Venneti, Jason T Huse
Current Neurology and Neuroscience Reports|November 24, 2021
The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021Alejandro Perez, Jason T Huse
Acta Neuropathologica Communications|April 30, 2025
Neurotransmitter power plays: the synaptic communication nexus shaping brain cancerJayanta Mondal, Jason T Huse
Neuro-Oncology|October 19, 2014
CMV and glioma--are we there yet?Jason T Huse, Kenneth Aldape
Pageof 19